https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49002 Wed 03 May 2023 12:09:58 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51639 Tue 12 Sep 2023 20:15:00 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:31793 Sat 24 Mar 2018 08:42:47 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:21465 DRD2 and several genes involved in glutamatergic neurotransmission highlight molecules of known and potential therapeutic relevance to schizophrenia, and are consistent with leading pathophysiological hypotheses. Independent of genes expressed in brain, associations were enriched among genes expressed in tissues that have important roles in immunity, providing support for the speculated link between the immune system and schizophrenia.]]> Sat 24 Mar 2018 07:52:31 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52684 Fri 20 Oct 2023 09:58:07 AEDT ]]>